DCF — ADVENTHEALTH TAMPA
Enterprise Value: $-962.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-962.7M
Enterprise Value
$-308.5M
PV of Cash Flows
$-654.2M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $720.1M | $-57.8M | -8.0% | $-88.3M | $-80.3M |
| Year 2 | $741.7M | $-52.1M | -7.0% | $-83.5M | $-69.0M |
| Year 3 | $764.0M | $-46.1M | -6.0% | $-78.4M | $-58.9M |
| Year 4 | $786.9M | $-43.5M | -6.0% | $-76.8M | $-52.5M |
| Year 5 | $810.5M | $-42.8M | -5.0% | $-77.1M | $-47.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-962.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$699.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08528032122352898
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5